New York, New York, Oct. 9, 2014 (GLOBE NEWSWIRE) -- Persistence Market Research Released New Market Report on "Global Market Study on Biological Drugs: North America to Witness Highest Growth by 2020" the global biological drugs market is estimated at USD 1, 61,056.5 million in 2014 and is expected to grow at a CAGR of 10.1% from 2014 to 2020, to reach an estimated value of USD 2, 87,139.7 million in 2020.
Browse the full Global Market Study on Biological Drugs: North America to Witness Highest Growth by 2020 report at http://www.persistencemarketresearch.com/market-research/global-biological-drugs-market.asp
The biological drugs market is witnessing a significant growth due to the increasing prevalence of chronic diseases and increase in the global geriatric population. Biological drugs are used in treatment and prevention of various diseases such as cancer, blood-related diseases, auto-immune diseases and other medical disorders. Moreover, various government associations are also promoting the usage of biological drugs. Furthermore, advancement in biomedical sciences holds immense potential for the growth of the biologic drugs market.
Biological drugs are typically derived from living cells and are used in treatment of various diseases such as cancer, blood-related diseases, auto-immune diseases and other medical disorders. Biological drugs have more complex structure than conventional drugs. These are highly sensitive and more difficult to characterize and produce. A biological drug typically has around 250 in-process tests during manufacturing compared to about 50 tests for a conventional drug.
The global market of biological drugs is categorized based on therapeutic protein, mAb and vaccines. The therapeutic protein segmentation is further sub-segmented into Enbrel, Lantus, Neulasta, Avonex, NovoLog, Rebif, Humalog, Aranesp, Epogen, Levemir, Victoza, Betaseron, Neupogen, and Eylea. The mAb segment comprises Humira, Remicade, Rituxan, Avastin, Herceptin and Lucentis. The vaccine segment is further sub-segmented into Prevnar 13, Gardasil, Fluzone, Varivax and Cervarix.
However, high cost of biological drugs and patent expiry of blockbuster drugs impede growth of the biological drugs market. Moreover, the risk of adverse effects associated with biologic injectable drugs is also one of the key restraints for biological drugs market. As a result, biological drugs market is expected to grow a CAGR of about 10.1% during 2014-2020.
North America is the largest market for biological drugs. Increased usage of biological drugs for the treatment of diseases such as cancer, diabetes and other chronic diseases are supporting the growth of the biological drugs market in the region. Moreover, several clinics in the region are focusing on biological drugs for the treatment of various chronic diseases. For instance, the American Center for Biological Medicine (ACBM) is one of the largest biological medicine clinics in the U.S.
Similarly, the European biological drugs market is growing rapidly due to increased usage of biological drugs for the treatment of various chronic diseases such as diabetes, cancer and inflammatory diseases.
In Asia, low manufacturing cost is attracting many biological manufactures to invest in Asian countries, supporting the growth of the biological drugs market. Moreover, Asian governments are also supporting in growth of the biological drugs market by increased investment on biotech companies for construction of R&D and manufacturing facilities.
Novartis AG, Pfizer Inc., GlaxoSmithKline plc. and Merck & Co., Inc. are some of the leading players in the global biological drugs market. Other major players of biological drugs market include Abbott Laboratories, Biogen Idec and Amgen Inc.
Latest Published Reports By PMR:
- Home Infusion Therapy Market: http://www.persistencemarketresearch.com/market-research/home-infusion-therapy-market.asp
- Sports Nutrition market: http://www.persistencemarketresearch.com/market-research/sports-nutrition-market.asp
- Microfluidic Devices Market: http://www.persistencemarketresearch.com/market-research/microfluidic-devices-market.asp
The global market of biological drugs is segmented as follows:
Biological Drugs Market, By Therapeutic Protein
- Enbrel
- Lantus
- Neulasta
- Avonex
- NovoLog
- Rebif
- Humalog
- Aranesp
- Epogen
- Levemir
- Victoza
- Betaseron
- Neupogen
- Eylea
Biological Drugs Market, By Monoclonal Antibody (mAb)
- Humira
- Remicade
- Rituxan
- Avastin
- Herceptin
- Lucentis
Biological Drugs Market, By Vaccine
- Prenvar 13
- Gardasil
- Fluzone
- Varivax
- Cervarix
Biological Drugs Market, by Geography
- North America
- Europe
- Asia
- Rest of the World (RoW)
About Us
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.
PMR stands committed to bringing more accuracy and speed to clients' business decisions. From ready-to-purchase market research reports to customized research solutions, PMR's engagement models are highly flexible without compromising on its deep-seated research values.